Hydroflumethiazide And Reserpine

Web NewDrugInformation.com

Hydroflumethiazide And Reserpine

Drug - Hydroflumethiazide And Reserpine
The trade name of the product as shown on the labeling.

The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Hydroflumethiazide; Reserpine
Multiple ingredients are in alphabetical order.

Strength - 25MG;0.125MG
The potency of the active ingredient(s), Hydroflumethiazide; Reserpine. May repeat for multiple part products.

Applicant - WATSON LABS
The firm name holding legal responsibility for Hydroflumethiazide And Reserpine. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088127
The FDA assigned number to Hydroflumethiazide And Reserpine. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Hydroflumethiazide And Reserpine. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 22, 1983
The date Hydroflumethiazide And Reserpine was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Hydroflumethiazide And Reserpine. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Hydroflumethiazide And Reserpine is in. Format is RX, OTC, DISCN.

Applicant Full Name - Watson Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Hydroflumethiazide And Reserpine.

Hydroflumethiazide And Reserpine